JP2024506718A5 - - Google Patents

Info

Publication number
JP2024506718A5
JP2024506718A5 JP2023549616A JP2023549616A JP2024506718A5 JP 2024506718 A5 JP2024506718 A5 JP 2024506718A5 JP 2023549616 A JP2023549616 A JP 2023549616A JP 2023549616 A JP2023549616 A JP 2023549616A JP 2024506718 A5 JP2024506718 A5 JP 2024506718A5
Authority
JP
Japan
Prior art keywords
aqueous solution
composition according
solution composition
polypeptide
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023549616A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024506718A (ja
Filing date
Publication date
Priority claimed from GBGB2102258.7A external-priority patent/GB202102258D0/en
Application filed filed Critical
Publication of JP2024506718A publication Critical patent/JP2024506718A/ja
Publication of JP2024506718A5 publication Critical patent/JP2024506718A5/ja
Pending legal-status Critical Current

Links

JP2023549616A 2021-02-17 2022-02-17 工学作成二量体タンパク質の安定性を高めるための水溶液組成物 Pending JP2024506718A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2102258.7A GB202102258D0 (en) 2021-02-17 2021-02-17 Novel composition
GB2102258.7 2021-02-17
PCT/US2022/016864 WO2022178175A1 (en) 2021-02-17 2022-02-17 Aqueous solution compositions for increasing stability of engineered dimeric proteins

Publications (2)

Publication Number Publication Date
JP2024506718A JP2024506718A (ja) 2024-02-14
JP2024506718A5 true JP2024506718A5 (https=) 2025-02-26

Family

ID=75338972

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023549616A Pending JP2024506718A (ja) 2021-02-17 2022-02-17 工学作成二量体タンパク質の安定性を高めるための水溶液組成物

Country Status (12)

Country Link
US (2) US20220265788A1 (https=)
EP (1) EP4294372A1 (https=)
JP (1) JP2024506718A (https=)
KR (1) KR20230147140A (https=)
CN (1) CN117279624A (https=)
AU (1) AU2022224607A1 (https=)
BR (1) BR112023016442A2 (https=)
CA (1) CA3208704A1 (https=)
GB (1) GB202102258D0 (https=)
IL (1) IL305142A (https=)
MX (1) MX2023009630A (https=)
WO (1) WO2022178175A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023225513A1 (en) * 2022-05-16 2023-11-23 Inhibrx, Inc. Effective dosage of recombinant serpin-fc fusion protein for use in a method of treating aat deficiency in a subject

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1478394T1 (sl) * 2002-02-27 2008-12-31 Immunex Corp STABILIZIRAN TNFR-Fc SESTAVEK Z ARGININOM
KR101235507B1 (ko) * 2003-02-28 2013-02-20 추가이 세이야쿠 가부시키가이샤 단백질을 함유하는 안정화 제제
ATE530165T1 (de) * 2003-11-14 2011-11-15 Baxter Int Alpha1-antitrypsin-zusammensetzungen und behandlungsverfahren unter verwendung dieser zusammensetzungen
PL1789434T3 (pl) * 2004-08-31 2014-07-31 Novo Nordisk As Zastosowanie tris(hydroksymetylo)aminometanu do stabilizacji peptydów, polipeptydów i białek
BRPI0611901A2 (pt) * 2005-06-14 2012-08-28 Amgen, Inc composição, liofilizado, kit, e, processo para preparar uma composição
AU2006318583A1 (en) * 2005-11-22 2007-05-31 Wyeth Immunoglobulin fusion protein formulations
GB0700523D0 (en) * 2007-01-11 2007-02-21 Insense Ltd The Stabilisation Of Proteins
EP2598167B1 (en) * 2010-07-30 2015-04-01 Arecor Limited Stabilized aqueous antibody compositions
EA201391489A1 (ru) * 2011-04-07 2014-02-28 ГЛЭКСОСМИТКЛАЙН ЭлЭлСи Композиции со сниженной вязкостью
KR102231139B1 (ko) 2011-06-28 2021-03-24 인히브릭스, 인크. 세르핀 융합 폴리펩타이드 및 이의 이용 방법
CA2896951A1 (en) * 2012-01-10 2013-07-18 The Regents Of The University Of Colorado, A Body Corporate Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
US9527890B2 (en) * 2013-06-18 2016-12-27 The Brigham And Womens's Hospital, Inc. FC receptor (FcRn) binding peptides and uses thereof
RU2727639C2 (ru) * 2014-01-15 2020-07-22 Ф.Хоффманн-Ля Рош Аг Варианты fc-области с модифицированной способностью связываться с fcrn и с сохраненной способностью связываться с белком а
EP3155117A4 (en) * 2014-06-11 2017-11-22 Beth Israel Deaconess Medical Center, Inc. Alpha1-antitrypsin compositions and methods of treating autoimmune diseases
NZ769391A (en) * 2014-10-27 2024-12-20 Sanofi Aatd Inc Serpin fusion polypeptides and methods of use thereof
GB201703063D0 (en) * 2017-02-24 2017-04-12 Arecor Ltd Stabilized antibody protein solutions
GB201721846D0 (en) * 2017-12-22 2018-02-07 Arecor Ltd Novel composition

Similar Documents

Publication Publication Date Title
US10772963B2 (en) Etanercept formulations stabilized with xylitol
TWI515006B (zh) 重組ｖｗｆ調配物
US20210007991A1 (en) Etanercept formulations exhibiting marked reduction in sub-visible particles
JP2005348744A (ja) 組織因子活性インヒビターの産生
JP6030201B2 (ja) α‐１プロテイナーゼインヒビターのための組成物、方法およびキット
JP2024506718A5 (https=)
AU2004288854B2 (en) Dry recombinant human alpha 1-antitrypsin formulation
KR100330540B1 (ko) 안티트롬빈-iii액상제제및그안정화방법
JP2024506718A (ja) 工学作成二量体タンパク質の安定性を高めるための水溶液組成物
JPWO1994022471A1 (ja) アンチトロンビン−３液状製剤およびその安定化方法
JP2022544216A5 (https=)
JP2722143B2 (ja) トリプシンインヒビター含有凍結乾燥製剤
JP2660484B2 (ja) ヒト尿性トリプシンインヒビター含有液状製剤
JPH0625011A (ja) ヒト尿性トリプシンインヒビター含有液状製剤及びその製造方法
CN119487056A (zh) 用于在治疗受试者的AAT缺乏症的方法中使用的有效剂量的重组丝氨酸蛋白酶抑制剂-Fc融合蛋白
JP2024507347A (ja) Ｆｃドメインを含む操作されたタンパク質コンストラクトの水性組成物
HK1200851B (en) Etanercept formulations stabilized with amino acids
HK1200720B (en) Etanercept formulations stabilized with combinations of sugars and polyols
HK1200719B (en) Etanercept formulations stabilized with metal ions